Cargando…
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
Prediction of hepatocellular carcinoma (HCC) risk becomes increasingly important with recently emerging HCC-predisposing conditions, namely non-alcoholic fatty liver disease and cured hepatitis C virus infection. These etiologies are accompanied with a relatively low HCC incidence rate (~1% per year...
Autores principales: | Kubota, Naoto, Fujiwara, Naoto, Hoshida, Yujin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761278/ https://www.ncbi.nlm.nih.gov/pubmed/33256232 http://dx.doi.org/10.3390/jcm9123843 |
Ejemplares similares
-
Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018) -
Hepatitis C virus-induced hepatocellular carcinoma
por: Goossens, Nicolas, et al.
Publicado: (2015) -
MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific in Silico Prognostic Biomarker Validation
por: Yip, Shun H., et al.
Publicado: (2019) -
Clinico‐histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease
por: Fujiwara, Naoto, et al.
Publicado: (2023) -
Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)